Female smokers often face unique barriers to quitting smoking. The purpose of this study is to examine how menstrual cycle/ female sex hormones may play a role in smoking outcomes. The study tests the feasibility of a menstrual-cycle timed smoking cessation program for female smokers between 18-40 years of age. Treatment consists of a six-week telephone-based behavioral counseling program along with provision of nicotine replacement therapy. Primary outcomes include determining acceptability and feasibility of the study by assessing the recruitment and retention rate and overall participant study satisfaction. Quit smoking outcomes are measured at end of the program and at 3 month follow-up.

Dr. Alicia M. Allen from the Department of Family and Community Medicine is the Co-PI on this project with Dr. Nair.